Nano-Biosensors for Early Diagnosis and Continuous Monitoring of Obesity-Linked Metabolic Disorders

Kato Jumba K.

Faculty of Science and Technology Kampala International University Uganda

                                                                                      ABSTRACT
Obesity is a key risk factor for several metabolic disorders, including type 2 diabetes (T2D), cardiovascular diseases, and fatty liver disease. Early diagnosis and continuous monitoring of these conditions are crucial for timely intervention and prevention of further complications. Nano-biosensors, leveraging the unique properties of nanomaterials, offer a promising solution for early detection and real-time monitoring of obesity-linked metabolic disorders. These sensors can detect specific biomarkers related to insulin resistance, inflammation, lipid metabolism, and glucose homeostasis with high sensitivity and selectivity. This review explores the principles, types, and applications of nano-biosensors for diagnosing and monitoring obesity-related metabolic disorders. It also discusses the challenges and future directions for integrating nano-biosensors into clinical
practice for improved patient management and personalized therapy.

Keywords: nano-biosensors, obesity, metabolic disorders, early diagnosis, continuous monitoring

CITE AS: Kato Jumba K. (2026). Nano-Biosensors for Early Diagnosis and Continuous Monitoring of Obesity-Linked Metabolic Disorders. NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY,7(1):56-61.
https://doi.org/10.59298/NIJPP/2026/715661